1. Home
  2. Advisory Committees
  3. Committees and Meeting Materials
  4. Blood, Vaccines and Other Biologics
  5. Vaccines and Related Biological Products Advisory Committee
  6. 2025 Meeting Materials, Vaccines and Related Biological Products Advisory Committee
  1. Vaccines and Related Biological Products Advisory Committee

2025 Meeting Materials, Vaccines and Related Biological Products Advisory Committee

October 9, 2025

The meeting presentations will be heard, viewed, captioned, and recorded through an online teleconferencing platform.

On October 9, 2025, the Committee will meet in open session to discuss and make recommendations on the following separate topics.

Under Topic I, the Committee will discuss and make recommendations on the strain selection for the influenza virus vaccines for the 2026 Southern Hemisphere influenza season.

Under Topic II, the Committee will discuss and make recommendations on advancing CBER’s allergen standardization program.

May 22, 2025

The meeting presentations will be heard, viewed, captioned, and recorded through an online teleconferencing platform.

On May 22, 2025, the committee will meet in open session to discuss and make recommendations on the selection of the 2025-2026 Formula for COVID-19 vaccines for use in the United States.

Back to Top